4.6 Article

Calnexin Deficiency Leads to Dysmyelination

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 285, 期 24, 页码 18928-18938

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.107201

关键词

-

资金

  1. National Institutes of Health [EYEY008768, F31AG032176]
  2. Canadian Institutes of Health Research [MOP-15291, MOP-8659, MOP-86470]
  3. Swiss National Science Foundation
  4. Retina Research Foundation
  5. Alberta Innovates-Health Solutions
  6. March of Dimes
  7. Davey Fund for Brain Research
  8. Multiple Sclerosis Society of Canada
  9. Heart and Stroke Foundation of Canada
  10. Membrane Protein Cardiovascular Disease Training Program

向作者/读者索取更多资源

Calnexin is a molecular chaperone and a component of the quality control of the secretory pathway. We have generated calnexin gene-deficient mice (cnx(-/)) and showed that calnexin deficiency leads to myelinopathy. Calnexin-deficient mice were viable with no discernible effects on other systems, including immune function, and instead they demonstrated dysmyelination as documented by reduced conductive velocity of nerve fibers and electron microscopy analysis of sciatic nerve and spinal cord. Myelin of the peripheral and central nervous systems of cnx(-/-) mice was disorganized and decompacted. There were no abnormalities in neuronal growth, no loss of neuronal fibers, and no change in fictive locomotor pattern in the absence of calnexin. This work reveals a previously unrecognized and important function of calnexin in myelination and provides new insights into the mechanisms responsible for myelin diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据